Dilazep
Top View
- Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
- Action of Dilazep Dihydrochloride on Chemiluminescence from a Xanthine Oxidase/Acetaldehyde System
- (12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
- Stembook 2018.Pdf
- Adenosine Receptor Agonists Deepen the Inhibition of Platelet Aggregation
- (12) United States Patent (10) Patent No.: US 6,989,376 B2 Watkins Et Al
- Infrared Reference Spectra
- Pharmaceuticals Appendix
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Active Adenosine Transporter-Mediated Adenosine Entrance Into HL-60 Cells Leads to the Induction of Apoptosis Through Down-Regulation of C-Myc
- Therapeutic Endoscopy-Related GI Bleeding and Thromboembolic
- FAST TOXICOLOGICAL SCREENING KIT by LC-MS/MS – Code SC9005B
- Effects of a Nucleoside Transporter Inhibitor, Dilazep, on Renal Microcirculation in Rats
- The University of Chicago Microbially-Regulated
- And Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells
- MAVENCLAD (Cladribine) Tablets, for Oral Use HIV Infection
- Rational Drug Design for Neglected Diseases: Implementation of Computational Methods to Construct Predictive Devices and Examine Mechanisms
- Targeting the Equilibrative Nucleoside Transporter ENT1 in Huntington Disease